These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 34026493)

  • 1. Remdesivir-induced symptomatic bradycardia in the treatment of COVID-19 disease.
    Jacinto JP; Patel M; Goh J; Yamamura K
    HeartRhythm Case Rep; 2021 Aug; 7(8):514-517. PubMed ID: 34026493
    [No Abstract]   [Full Text] [Related]  

  • 2. Remdesivir-Induced Marked Sinus Bradycardia in COVID-19.
    Ahmed T; Lodhi SH; Ahmed T
    Cureus; 2022 Jul; 14(7):e27249. PubMed ID: 36035063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sinus Bradycardia Associated with Remdesivir Treatment in COVID-19: A Case Report and Literature Review.
    Barkas F; Styla CP; Bechlioulis A; Milionis H; Liberopoulos E
    J Cardiovasc Dev Dis; 2021 Feb; 8(2):. PubMed ID: 33673216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Adverse Events With Remdesivir in COVID-19 Infection.
    Gupta AK; Parker BM; Priyadarshi V; Parker J
    Cureus; 2020 Oct; 12(10):e11132. PubMed ID: 33240723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked Sinus Bradycardia Associated With Remdesivir in COVID-19: A Case and Literature Review.
    Gubitosa JC; Kakar P; Gerula C; Nossa H; Finkel D; Wong K; Khatri M; Ali H
    JACC Case Rep; 2020 Nov; 2(14):2260-2264. PubMed ID: 33163977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019.
    Montastruc F; Thuriot S; Durrieu G
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2835-2836. PubMed ID: 32721580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report.
    Anderson J; Schauer J; Bryant S; Graves CR
    Case Rep Womens Health; 2020 Jul; 27():e00221. PubMed ID: 32426243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The journey of remdesivir: from Ebola to COVID-19.
    Pardo J; Shukla AM; Chamarthi G; Gupte A
    Drugs Context; 2020; 9():. PubMed ID: 32547625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential.
    Deb S; Reeves AA; Hopefl R; Bejusca R
    Pharmaceuticals (Basel); 2021 Jul; 14(7):. PubMed ID: 34358081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic manifestations of COVID-19 and effect of remdesivir on liver function in patients with COVID-19 illness.
    Aleem A; Mahadevaiah G; Shariff N; Kothadia JP
    Proc (Bayl Univ Med Cent); 2021 Mar; 34(4):473-477. PubMed ID: 34219928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remdesivir Treatment for COVID 19 in Pregnant Patients with Moderate to Severe Symptoms: Serial Case Report.
    Saroyo YB; Rumondang A; Febriana IS; Harzif AK; Irwinda R
    Infect Dis Rep; 2021 May; 13(2):437-443. PubMed ID: 34067822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment.
    Davies M; Osborne V; Lane S; Roy D; Dhanda S; Evans A; Shakir S
    Drug Saf; 2020 Jul; 43(7):645-656. PubMed ID: 32468196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing an Ethics Framework for Allocating Remdesivir in the COVID-19 Pandemic.
    Lim S; DeBruin DA; Leider JP; Sederstrom N; Lynfield R; Baker JV; Kline S; Kesler S; Rizza S; Wu J; Sharp RR; Wolf SM
    Mayo Clin Proc; 2020 Sep; 95(9):1946-1954. PubMed ID: 32861338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic sinus bradycardia due to electrolyte imbalances in syndrome of inappropriate antidiuretic hormone (SIADH) related covid-19: a case report.
    Amir M; Renata A; Ratana LT
    BMC Infect Dis; 2021 May; 21(1):465. PubMed ID: 34020617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit.
    Sun D
    AAPS J; 2020 May; 22(4):77. PubMed ID: 32458279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Sinus Bradycardia: An Unusual Cardiac Manifestation of COVID-19.
    Ali M; Awadelkarim A; Bishop P; Alhusain R; Adam O; Subahi A; Elmoghrabi A; Afonso L
    J Investig Med High Impact Case Rep; 2021; 9():23247096211013185. PubMed ID: 33969726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    de Wit E; Feldmann F; Cronin J; Jordan R; Okumura A; Thomas T; Scott D; Cihlar T; Feldmann H
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6771-6776. PubMed ID: 32054787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19).
    Pallotto C; Blanc P; Esperti S; Suardi LR; Gabbuti A; Vichi F; Mecocci L; Esposti AD; Pierotti P; Attala L; Salomoni E; Baragli F; Francisci D; Pietro MAD
    J Infect; 2021 Aug; 83(2):237-279. PubMed ID: 34052239
    [No Abstract]   [Full Text] [Related]  

  • 19. Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study.
    Attena E; Albani S; Maraolo AE; Mollica M; De Rosa A; Pisapia R; Fiorentino G; Parrella R; Severino S; Russo V
    Circ Arrhythm Electrophysiol; 2021 Jul; 14(7):e009811. PubMed ID: 34182791
    [No Abstract]   [Full Text] [Related]  

  • 20. Sinus Bradycardia in a Pediatric Patient Treated With Remdesivir for Acute Coronavirus Disease 2019: A Case Report and a Review of the Literature.
    Chow EJ; Maust B; Kazmier KM; Stokes C
    J Pediatric Infect Dis Soc; 2021 Oct; 10(9):926-929. PubMed ID: 34173663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.